<div class="p4l_caption"><div class="p4l_captionTitle"><a target="_blank" href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3343650/" ref="ordinalpos=1983&amp;ncbi_uid=4852938&amp;link_uid=PMC3343650" image-link="/pmc/articles/PMC3343650/figure/fig5/" class="imagepopup">Figure 5.  From: RNA-seq analysis of prostate cancer in the Chinese population identifies recurrent gene fusions, cancer-associated long noncoding RNAs and aberrant alternative splicings. </a></div><br /><div class="p4l_captionBody">Three major signaling pathways are altered in prostate cancers. <b>(A)</b> Genes altered in the RAS-PI3K-AKT pathway. <b>(B)</b> Genes altered in the AR signaling pathway. <b>(C)</b> Genes altered in the RB signaling pathway. The activated genes are colored in a red gradient, and the inactivated genes are colored in a blue gradient according to the percentage of alterations in the 14 prostate cancer samples. The darker the color, the greater the percentage.</div></div>